Global Exosome Research Market is valued at USD 65.1 Million in 2024, and it is expected to reach USD 331.7 Million by 2034, with a CAGR of 18.0% during the forecast period of 2025-2034.
The demand for exosome research products has grown due to the growing use of specialized testing services such as liquid chromatography-mass spectrometry, RNA sequencing, wet chemistry, gene expressions, and various other testing services. These testing services are also increasingly used because of their ability to produce precise and accurate results, which has increased their use by end users.
The rising incidence of cancer, improvements in exosome separation and analysis techniques, and increased exosome-based advanced applications are expected to fuel market expansion. The rising number of cancer patients directly impacts the increased demand for exosomes. Exosome use in treating cancer is anticipated to increase due to the increased number of cancer cases, which is anticipated to boost the market. Furthermore, due to their improved passive targeting, enhanced tiny size, native nature, and capacity to traverse biological barriers, exosomes produced from body regions are intriguing candidates for anti-cancer vaccines. As a result, there is a clear correlation between the rise in cancer cases in hospitals and the demand for exosomes for therapeutic and diagnostic purposes.
However, several technological issues must be resolved to integrate exosomes in various applications successfully. One of the main obstacles to expanding the exosome market is this.
Additionally, research and development involving exosomes decreased due to nationwide lockdown regulations, supply chain disruptions, and investment shifts toward COVID-19-related products. Despite the negative effects, the COVID-19 pandemic has created several new opportunities for using exosomes in developing COVID-19 vaccines and therapies. This, in turn, is anticipated to accelerate industrial growth.
The exosome research market is segmented based on products & services, disease indications, applications and end users. Based on products & Services, the Exosome Research market is segmented as kits and reagents, instruments and services. By indication, the Exosome Research market is segmented into cancer, neurodegenerative diseases, cardiovascular diseases, and infectious diseases. By application, the market is segmented into biomarkers, vaccine development, tissue regeneration and other applications. By end users, the market is segmented into academic & research institutes, pharmaceutical and biotechnology companies, hospitals & clinical testing laboratories.
The kits & reagents category will hold a major share of the global Exosome Research market in 2022. Since circulating exosome microRNAs hold great promise as biomarkers, exosomes must be thoroughly characterized. As a result, simple-to-use reagents and kit designs have been created, promoting the usage of these tools in exosome research. The crucial isolation and purification steps are also necessary for exosome research methods, hastening their widespread commercialization. From various biological fluids, such as serum, plasma, and blood, these kits can extract exosomes and EV. Specialty purification and spin-column technology are also used to purify exosomes; these methods outperform traditional isolation methods, such as density gradient centrifugation and ultracentrifugation. Exosomes and other extracellular vesicles can be produced in large quantities with this technology from an incredibly clean cell culture media.
The neurodegenerative disorders segment is projected to grow rapidly in the global Exosome Research market. The major cause of disability and mortality and a significant financial burden on healthcare systems continue to be neurodegenerative disorders. Exosomes have a role in removing waste products from the nervous system, maintaining myelin sheath, and maintaining intercellular communication. Increased frequency of neurodegenerative disorders, improvements in exosome isolation and analysis methods, and an increase in the number of complex exosome applications are anticipated to be the causes of this rise.
The North America Exosome Research market is expected to register the highest market share due to improved healthcare structures, strong public regulations, many multinational corporations, and significant public awareness of diagnostics and healthcare. The use of exosome-based medications in treating cancers such as cancer of the skin, breast, lung, and pancreatic has been the subject of numerous government-funded studies of research. Clinical trials are being carried out in the United States thanks to sponsorship from businesses like Merck and Exosome Diagnostic and partnerships with schools like Yale and Michigan State.
Furthermore, government funding for these projects is superior, and most of the studies were done for neoplasms. In addition, Asia Pacific is projected to increase in the global Exosome Research market. The rise in government financing for discovering new biomarkers and the growing incidence of chronic diseases like cancer and cardiovascular disease is boosting the regional demand. The category is also expected to rise due to expanding research and development efforts to create novel medications, diagnostic techniques, and treatment choices.
|
Report Attribute |
Specifications |
|
Market size value in 2024 |
USD 65.1 Million |
|
Revenue forecast in 2034 |
USD 331.7 Million |
|
Growth rate CAGR |
CAGR of 18.0% from 2025 to 2034 |
|
Quantitative units |
Representation of revenue in US$ Mn,and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
|
Segments covered |
Products & Services, Indications, Applications And End Users |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
|
Competitive Landscape |
Thermo Fisher Scientific, System Biosciences, Bio-Techne, Lonza, QIAGEN, ExoDx, Hitachi Chemical, Aethlon Medical, NanoSomiX, Malvern Panalytical, Sistemic Scotland Limited, NX PharmaGen, Miltenyi Biotec, AMS Biotechnology, Norgen Biotec, Novus Biologicals, BioVision, Pall Corporation, Exopharm, and EverZom. |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Exosome Research Market Snapshot
Chapter 4. Global Exosome Research Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product & Service Estimates & Trend Analysis
5.1. by Product & Service & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product & Service:
5.2.1. Kits & Reagents
5.2.1.1. Antibodies
5.2.1.2. Isolation, Purification, Quantitation Kits & Reagents
5.2.1.3. Other Kits & Reagents
5.2.2. Instruments
5.2.3. Services
Chapter 6. Market Segmentation 2: by Disease Indication Estimates & Trend Analysis
6.1. by Disease Indication & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Disease Indication:
6.2.1. Cancer
6.2.1.1. Lung Cancer
6.2.1.2. Breast Cancer
6.2.1.3. Prostate Cancer
6.2.1.4. Colorectal Cancer
6.2.1.5. Other Cancers
6.2.2. Neurodegenerative Diseases
6.2.3. Cardiovascular Diseases
6.2.4. Infectious Diseases
6.2.5. Other Indications
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
7.2.1. Biomarkers
7.2.2. Vaccine Development
7.2.3. Tissue Regeneration
7.2.4. Other Applications
Chapter 8. Market Segmentation 4: by End User Estimates & Trend Analysis
8.1. by End User & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End User:
8.2.1. Academic & Research Institutes
8.2.2. Pharmaceutical & Biotechnology Companies
8.2.3. Hospital & Clinical Testing Laboratories
Chapter 9. Exosome Research Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Exosome Research Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2021-2034
9.1.2. North America Exosome Research Market Revenue (US$ Million) Estimates and Forecasts by Disease Indication, 2021-2034
9.1.3. North America Exosome Research Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.1.4. North America Exosome Research Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.1.5. North America Exosome Research Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Exosome Research Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2021-2034
9.2.2. Europe Exosome Research Market Revenue (US$ Million) Estimates and Forecasts by Disease Indication, 2021-2034
9.2.3. Europe Exosome Research Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.2.4. Europe Exosome Research Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.2.5. Europe Exosome Research Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Exosome Research Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2021-2034
9.3.2. Asia Pacific Exosome Research Market Revenue (US$ Million) Estimates and Forecasts by Disease Indication, 2021-2034
9.3.3. Asia-Pacific Exosome Research Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.3.4. Asia-Pacific Exosome Research Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.3.5. Asia Pacific Exosome Research Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Exosome Research Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2021-2034
9.4.2. Latin America Exosome Research Market Revenue (US$ Million) Estimates and Forecasts by Disease Indication, 2021-2034
9.4.3. Latin America Exosome Research Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.4.4. Latin America Exosome Research Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.4.5. Latin America Exosome Research Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Exosome Research Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2021-2034
9.5.2. Middle East & Africa Exosome Research Market Revenue (US$ Million) Estimates and Forecasts by Disease Indication, 2021-2034
9.5.3. Middle East & Africa Exosome Research Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.5.4. Middle East & Africa Exosome Research Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.5.5. Middle East & Africa Exosome Research Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Thermo Fisher Scientific
10.2.2. System Bioscience
10.2.3. Bio-Techne
10.2.4. Lonza
10.2.5. QIAGEN
10.2.6. ExoDx
10.2.7. Hitachi Chemical
10.2.8. Medica
10.2.9. NanoSomiX
10.2.10. Malvern Panalytical
10.2.11. Sistemic Scotland Limited
10.2.12. NX PharmaGen
10.2.13. Miltenyi Biotec
10.2.14. AMS Biotechnology
10.2.15. Norgen Biotek
10.2.16. Novus Biologicals
10.2.17. BioVision
10.2.18. Pall Corporation
10.2.19. Exopharm
10.2.20. EverZom
10.2.21. Other Prominent Players
Exosome Research Market By Product-
Exosome Research Market By Disease Indication-
Exosome Research Market By Applications
Exosome Research Market By End Users
Exosome Research Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
